RESMED INC【RMD】Income statement

Market cap

$36.7B

P/E ratio

	2011/06	2012/06	2013/06	2014/06	2015/06	2016/06	2017/06	2018/06	2019/06	2020/06	2021/06	2022/06	2023/06	2024/06	2025/06
Revenue	1,243	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146
Revenue growth (%)	-
Cost of revenue	502	548	574	565	668	772	865	978	1,070	1,239	1,358	1,554	1,867	2,030	2,091
Gross profit	741	821	941	990	1,011	1,066	1,202	1,362	1,537	1,718	1,839	2,024	2,356	2,655	3,055
Gross margin (%)
Research & development	92	110	120	118	115	119	144	155	181	202	225	254	288	308	331
Selling, general & administrative	371	402	431	450	479	488	554	600	645	677	670	739	874	917	991
Operating margin (%)
Operating income	267	294	355	405	409	429	426	542	579	810	904	1,000	1,132	1,320	1,685
Operating expenses	474	526	586	585	602	638	776	820	957	908	935	1,024	1,224	1,335	1,370
Income before tax	304	332	385	431	436	440	419	521	519	733	884	960	1,102	1,265	1,678
Pretax margin (%)	24.4	24.3	25.4	27.7	26	23.9	20.3	22.3	19.9	24.8	27.6	26.8	26.1	27	32.6
Provision for income taxes	77	77	78	86	83	87	76	206	114	111	409	181	204	244	277
Effective tax rate (%)
Net income	227	255	307	345	353	352	342	316	405	622	475	779	898	1,021	1,401
Net income margin (%)
Earnings per share	1.49	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94	9.55
Diluted EPS	1.44	1.71	2.1	2.39	2.47	2.49	2.4	2.19	2.8	4.27	3.24	5.3	6.09	6.92	9.51
Dividend payout ratio (%)	-	-
Dividend per share	-	-	0.68	1	1.12	1.2	1.32	1.4	1.48	1.56	1.56	1.68	1.76	1.92	2.12
EBITDA
EBITDA margin (%)